ArticleFrontiers in neurology2025

Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations.

Joaquim J Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.